Mechanism

Mechanism class undisclosed. Privileged-structure platform screened for SMN2 expression activity (collaboration with Nemours Alfred I. DuPont Hospital for Children, Sept 2013).

Approved indications

Related claims (0)

No claims matched “aurimmed sma small molecule” in free-text search.

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.